Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 2/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | MYC | P01106 | 1/20 | 0.45 |
| ▸ | MAX | P61244 | 1/20 | 0.45 |
| ▸ | AR | P10275 | 1/20 | 0.45 |
| ▸ | HTR7 | P34969 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28914441 | 0.86 | POLB (0.57) | ALDH1A1MAPK1POLBMAPTSMN1; SMN2 | |
| SCHEMBL2547080 | 0.85 | MYC (0.56) | ALDH1A1MAPK1POLBMAPTSMN1; SMN2 | |
| SCHEMBL6438984 | 0.83 | MAPK1 (0.53) | ALDH1A1MAPK1POLBMAPTSMN1; SMN2 | |
| SCHEMBL6536287 | 0.83 | ALDH1A1 (0.53) | ALDH1A1MAPK1POLBMAPTSMN1; SMN2 | |
| SCHEMBL9457556 | 0.83 | BCAT2 (0.62) | ALDH1A1MAPK1POLBMAPTSMN1; SMN2 | |
| SCHEMBL31590561 | 0.83 | ALDH1A1 (0.55) | ALDH1A1MAPTSMN1; SMN2CES1CES2 | |
| SCHEMBL11318957 | 0.83 | CTSD (0.58) | ALDH1A1MAPK1POLBMAPTSMN1; SMN2 | |
| SCHEMBL7083803 | 0.81 | POLB (0.56) | ALDH1A1MAPK1POLBMAPTSMN1; SMN2 | |
| SCHEMBL28964534 | 0.80 | MAPK1 (0.54) | ALDH1A1MAPK1POLBMAPTSMN1; SMN2 | |
| SCHEMBL27845352 | 0.80 | CTSD (0.43) | ALDH1A1MAPK1POLBMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040420-A | Heterocyclic-pyrazole amine derivatives, preparation method thereof and application thereof in resisting tubercle bacillus infection | 中国医学科学院医药生物技术研究所 | 2025-05-27 | — | — | CN | disclosed |
| CN-118678974-A | Curable formulations containing collagen | 科弗朗有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-111566100-B | Pyrimidine compound, preparation method and medical application thereof | 恩瑞生物医药科技（上海）有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-116744928-A | Quinolines modulating SERCA and their use for treating diseases | 神经元公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-110698459-B | 1-phenyl-2-pyridylalkyl alcohol derivatives as phosphodiesterase inhibitors | 奇斯药制品公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-105294664-A | Compound and preparation method thereof, liquid crystal aligning agent, liquid crystal aligning membrane and liquid crystal cell | FUYANG XINYIHUA MATERIAL TECHNOLOGY CO LTD | 2016-02-03 | — | — | CN | disclosed |
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | APOB, APOL1, SCARB1 | ALDH1A1 1427/4885MAPK1 1542/4885POLB 1470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.